Hear Sue Nemetz and the Corval team as they discuss the role of technology in creating a paradigm shift in biopharma commercialization planning.

The dynamic financial environment brings increased pressures and magnifies familiar pain points for emerging companies, elevating the need for a new approach to help teams get a fast, efficient, and early start on commercialization planning.